Similar articles

• Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.

  Van Schil PE. Van Schil PE. J Thorac Cardiovasc Surg. 2008 Mar;135(3):718; author reply 718-9. doi: 10.1016/j.jtcvs.2007.10.052. J Thorac Cardiovasc Surg. 2008. PMID: 18329516 No abstract available.
• Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.

  Johnson DH, Rusch VW, Turrisi AT. Johnson DH, et al. J Natl Cancer Inst. 2007 Mar 21;99(6):415-8. doi: 10.1093/jnci/djk107. J Natl Cancer Inst. 2007. PMID: 17374824 No abstract available.
• A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).

  Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group. Nagai K, et al. J Thorac Cardiovasc Surg. 2003 Feb;125(2):254-60. doi: 10.1067/mtc.2003.15. J Thorac Cardiovasc Surg. 2003. PMID: 12579093 Clinical Trial.
• [Chemotherapy for lung cancer].

  Kurata T, Fukuoka M. Kurata T, et al. Nihon Rinsho. 2002 May;60 Suppl 5:309-16. Nihon Rinsho. 2002. PMID: 12101679 Review. Japanese. No abstract available.
• [Advances in the diagnosis and treatment of lung cancer. I. Management of non-small cell carcinoma].

  Spiro SG. Spiro SG. Pneumonol Pol. 1990 Apr-May;58(4-5):239-43. Pneumonol Pol. 1990. PMID: 2168045 Review. Polish. No abstract available.